Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06694103

The Effect of Two Non-Pharmacological Methods on Pain During Retinopathy Examination

The goal of this randomized controlled trial is to determine the effect of reverse kangaroo care position and ROP (Retinopathy of Prematurity) position applied during ROP examination in premature infants on pain. The main questions it aims to answer are as follows:

1. Is the reverse kangaroo care position effective in reducing the pain of premature infants during the ROP examination? 2. Is the reverse kangaroo care position more effective in reducing the pain of premature infants compared to the ROP position during the ROP examination?

Researchers will determine the effect of reverse kangaroo care position and ROP position applied during premature retinopathy examination in premature infants with a gestational age of less than 34 weeks on pain in infants.

* The infants of parents who volunteer to participate in the study will be divided into two groups as Reverse Kangaroo Care Position group and ROP Position group according to randomization. * From the infants whose pupils are sufficiently mydriasis and are taken to the examination table, premature infants in the ROP Position group will be given ROP position together with the nurse and the parent. * Premature infants in the Reverse Kangaroo Care Position group will be given reverse kangaroo care position. * Video recording will be made during the given positions. * The effects of the applied positions on pain will be determined as a result of the measured parameters before, during and after the examination.

Recruiting

Interested in participating?

Request Info

Key information

Age range

28 week–33 week

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Izmır Provincial Health Directorate Bakircay University Cigli Regional Educational Hospital

Izmir, Menemen, 35610, Turkey (Türkiye)

Location status: Recruiting

Location contact

Hatice Bal Yılmaz, Prof. Dr.

CONTACT

[email protected]

+905321323756

Hatice Bal Yılmaz, Prof. Dr.

PRINCIPAL_INVESTIGATOR

Sinem Başdemir, Research Assistant

CONTACT

[email protected]

+905550074974

Sinem Başdemir, Research Assistant

SUB_INVESTIGATOR

About this study

  • 84 premature infants that meet the sample criteria will be determined.
  • Randomization will be performed and premature babies will be assigned to the Reverse Kangaroo Care Position (Group 1) and Rope Position (Group 2) groups.
  • The purpose of the study will be explained to the mother by meeting her and written consent will be obtained.
  • The Premature Identification Form, which includes information about the infant, will be filled out.

According to the groups to which the premature infants who were randomized were assigned;

One minute before the examination;

  • The infants will be placed on the examination table and one drop of %0.5 alcaine (proparacaine HCl) topical anesthetic eye drops will be applied to both eyes of the premature infantss assigned to both groups by the neonatal intensive care nurse.
  • The pulse oximetry probe will be attached to the infants' right feet and monitored.
  • The infants will be positioned according to the group they are assigned to.
  • Video recording will be started one minute before the examination and will continue until 1 minute after the examination.
  • In order to evaluate the SPO2, KTA, PIPP-R values of all groups at the 15th second before the examination, the infant will be recorded on video for one minute.

During the Examination; In the Reverse Kangaroo Care Position Group;

  • While the reverse kangaroo care position applied to the infants is maintained, the speculum is placed on the eye by the ophthalmologist and the video recording will continue throughout the examination from the moment the examination begins
  • The SPO2, KTA, PIPP-R in the 1st minute of the examination will be recorded for evaluation

In the ROP Position Group;

  • While the ROP position applied to the babies is maintained, the speculum is placed on the eye by the ophthalmologist and the video recording will continue throughout the examination from the moment the examination begins
  • The SPO2, KTA, PIPP-R in the 1st minute of the examination will be recorded for evaluation

At the end of the examination;

  • After the completion of both eye examinations, the video recording will continue for 1 more minute while the positions of the babies whose monitoring continues are maintained
  • The video recording will end 1 minute after the examination ends
  • The infant's SPO2, KTA, values, PIPP-R pain score will be evaluated and recorded
  • . The aim is to record the infant's SPO2 and KTA values at 30 seconds so that the PIPP-R pain score can be evaluated later.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Gestational age <34 weeks,
  • Birth weight ≤ 2500 grams,
  • No painful interventions at least 1 hour before the ROP examination,
  • Fed at least 1 hour before the ROP examination,
  • Premature infants whose parents consented to participate in the study.

Exclusion criteria

  • Having a condition that prevents pain assessment (intracranial hemorrhage, neuromotor developmental delay etc.)
  • Any congenital anomaly (eye, neurological, etc.),
  • Have a diagnosed hearing problem,
  • A different painful procedure was performed at least one hour before the ROP examination,
  • Administration of an analgesic/sedative medication before the examination,
  • Premature infants whose parents did not consent to participate in the study.

Treatment and study plan

Reverse Kangaroo Care Position

Other
  • Babies will be taken to the examination table and their clothes other than diapers will be removed.
  • Mothers will take off their upper clothes and lie on the examination table and position their babies in the reverse kangaroo care position, with the baby's back against the mother's bare chest.
  • Babies will be monitored with disposable probes from their right feet.
  • Video recording will be started. -While the position applied to the babies is maintained, the speculum will be placed in the eye by the ophthalmologist and the examination will be recorded on video from the beginning to end.
  • After the completion of both eye examinations, the position of the babies whose monitoring continues will be maintained while the video recording will be taken for another 1 minute. The SPO2, HR, PIPP-R score at the end of the 15th second before the examination, the first minute during the examination and the 30th second after the examination will be evaluated.

ROP Position

Other
  • Babies will be taken to the examination table and monitored with disposable probes from their right feet.
  • The nurse will place the infant's own palms on the temporal region and hold them with her hands to support their head, while the mother will also support the infant by holding their legs.
  • The video recording will be started.
  • SPO2, HR, PIPP-R values will be recorded on video for one minute.
  • While the ROP position applied to the babies is maintained, the speculum is placed in the eye by the ophthalmologist and the examination begins.
  • SPO2, HR, PIPP-R evaluation at the 1st minute of the examination.
  • After the completion of both eye examinations, the babies whose monitoring continues will be kept in their positions and a video recording will be taken for another 1 minute.
  • The SPO2, HR values and PIPP-R pain score at the end of the 30 seconds after the examination will be evaluated.

Primary outcomes

  1. Premature Introductory Information Form:

    Time frame: Pre-intervention

    It was prepared by the researcher to determine the characteristics of the premature babies participating in the study. It consists of seven questions including the baby's gender, gestational week, birth weight, postnatal week, delivery method, birth head circumference and height measurement.

  2. Premature Infant Follow-up Form

    Time frame: 15th minute before the examination; 1st minute during the examination, 30 seconds after the examination

    It consists of fields including the premature infant's heart rate, oxygen saturation values and PIPP-R score at the 15th second before the examination, the 1st minute during the examination and the 30 seconds after the examination.

  3. Premature Infant Pain Profile Scale-Revised Form (PIPP-R)

    Time frame: 15th second before the examination; 1st minute during the examination, 30 seconds after the examination

    It is a Likert-type scale. In the scoring of the scale, items related to physiological and behavioral indicators are scored as 0, 1, 2 and 3 points for each variable. Items related to contextual indicators (behavioral status and gestational age) are scored as 3, 2, 1 and 0 points at the beginning of the pain assessment (before contact with the baby). According to PIPP-R, the infant's pain is evaluated based on the total score. In scoring the PIPP-R, behavioral and physiological indicators are scored at the end of the scale. Accordingly, if the infant receives a zero score (subtotal) from the general physiological and behavioral indicators, the contextual indicators are not scored. If the infant receives a score above zero from the initial parameters, the total score is obtained by including the contextual indicators in the scoring. The highest score of the PIPP-R is 21 for preterm infants and 18 for term infants (Stevens et al., 2014).

Study contacts

Contact information is provided by the study sponsor or research team.

Sayime Aydın Eroğlu, Associate Professor

CONTACT

[email protected]

+905338180576

Sinem Başdemir, Research Assistant

CONTACT

[email protected]

+905550074974

Sponsors and collaborators

Lead sponsor

Sinem Basdemir

Other

Registry information

Official study title

The Effect of Reverse Kangaroo Care Position and ROP Position on Pain During Retinopathy Examination in Premature Infants

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Nov 19, 2024
Registry last updated
Nov 19, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.